Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma
โ Scribed by Jyotsna M. Bhatavdekar; Devendra D. Patel; Nandita Ghosh; Priya R. Chikhlikar; Trupti I. Trivedi; Tejal P. Suthar; Sonali S. Doctor; Neelam G. Shah; Damodar B. Balar
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 491 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0012-3706
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
BACKGROUND. The objective of this study was to evaluate intratumoral neoangiogenesis in Dukes Stage B and Stage C (AJCC/UICC Stage I and III) colorectal adenocarcinoma and its correlation with nuclear p53 oncoprotein accumulation and cytoplasmic bcl-2 expression as well as to assess the prognostic s
The aim of this study was to ascertain whether apoptotic counts have prognostic significance in colorectal cancer and if such counts are related to the expression of proteins implicated in cell cycle regulation. Material from a cohort of patients aged 45 years or less with colorectal carcinoma was r
## Abstract ## Background Cyclooxygenase (COX)โ2 is believed to be an important enzyme related to the pathogenesis of colorectal cancer (CRC). p53 has been reported to be a negative regulator of COXโ2 expression in in vitro studies. The aim of this study was to investigate COXโ2 expression and its
Apoptosis is an important physiological process controlled by multiple genes, including c-myc, p53 and bcl-2, and its inhibition may lead to the development of human cancers. In this study, we analyzed expression of the c-myc gene using Northern blot and of the p53 and bcl-2 proteins by immunohistoc